Lumira Ventures
Nikhil Thatte is a seasoned professional in the healthcare investment sector, currently serving as a Partner at Lumira Ventures since March 2019. In this role, Nikhil holds positions on the Board of Directors for Specific Biologics, Alpina Biotechnology, and Biotheryx, while also acting as a Board Observer for COUR Pharmaceuticals and XyloCor Therapeutics. Nikhil previously worked at DRI Capital from June 2016 to December 2018, where responsibilities included business development, deal sourcing, and due diligence for Canada's largest dedicated healthcare private equity firm. Nikhil's earlier experience includes roles in business analytics and consulting at ZS Associates, Bayer, and Health Canada. Nikhil holds a Bachelor’s degree in Chemical Engineering from McGill University.
This person is not in any teams
This person is not in any offices
Lumira Ventures
Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer, and more productive lives.